ISIS PHARMACEUTICALS INC's ticker is ISIS and the CUSIP is 464330109. A total of 172 filers reported holding ISIS PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $694,941,000 | -94.3% | 17,193 | -91.8% | 0.00% | -94.1% |
| Q2 2015 | $12,103,801,000 | +5866.8% | 210,318 | +6501.3% | 0.03% | +3300.0% |
| Q1 2015 | $202,852,000 | +7042.7% | 3,186 | +6826.1% | 0.00% | – |
| Q4 2014 | $2,840,000 | -98.9% | 46 | -99.3% | 0.00% | – |
| Q3 2014 | $268,587,000 | -2.1% | 6,917 | -13.2% | 0.00% | – |
| Q2 2014 | $274,429,000 | +27044.3% | 7,966 | +20863.2% | 0.00% | – |
| Q1 2014 | $1,011,000 | -98.3% | 38 | -97.4% | 0.00% | – |
| Q4 2013 | $58,047,000 | -96.0% | 1,457 | -96.3% | 0.00% | -100.0% |
| Q3 2013 | $1,468,380,000 | -99.2% | 39,115 | -96.2% | 0.00% | -99.2% |
| Q2 2013 | $175,753,060,000 | – | 1,039,563 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BB BIOTECH AG | 7,202,585 | $270,385,000 | 14.71% |
| DOWLING & YAHNKE LLC | 675,798 | $25,369,000 | 3.98% |
| GARRISON BRADFORD & ASSOCIATES INC | 100,700 | $3,780,000 | 3.87% |
| WILLIAM HARRIS INVESTORS INC | 312,834 | $11,743,000 | 3.67% |
| Meditor Group Ltd | 490,000 | $18,395,000 | 2.59% |
| AVALON CAPITAL MANAGEMENT | 50,943 | $1,912,000 | 1.89% |
| Orinda Asset Management LLC | 14,665 | $551,000 | 1.73% |
| PINNACLE ASSOCIATES LTD | 2,064,760 | $77,511,000 | 1.60% |
| PERKINS CAPITAL MANAGEMENT INC | 52,850 | $1,984,000 | 1.43% |
| NCM Capital Advisers, Inc. | 24,950 | $937,000 | 1.04% |